Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1991 2
1992 2
1993 4
1994 4
1995 9
1998 2
1999 3
2000 3
2001 3
2002 2
2003 2
2004 1
2007 2
2009 3
2010 2
2011 3
2012 3
2013 3
2014 7
2015 4
2016 6
2017 7
2018 9
2019 5
2020 6
2021 5
2022 9
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Primary Sclerosing Cholangitis.
Noroski LM, Fuleihan R. Noroski LM, et al. Among authors: fuleihan r. N Engl J Med. 2016 Dec 22;375(25):2501. doi: 10.1056/NEJMc1613273. N Engl J Med. 2016. PMID: 28002708 No abstract available.
The hyper IgM syndromes.
Qamar N, Fuleihan RL. Qamar N, et al. Among authors: fuleihan rl. Clin Rev Allergy Immunol. 2014 Apr;46(2):120-30. doi: 10.1007/s12016-013-8378-7. Clin Rev Allergy Immunol. 2014. PMID: 23797640 Review.
New primary immunodeficiencies 2021 context and future.
Demirdag Y, Fuleihan R, Orange JS, Yu JE. Demirdag Y, et al. Among authors: fuleihan r. Curr Opin Pediatr. 2021 Dec 1;33(6):657-675. doi: 10.1097/MOP.0000000000001075. Curr Opin Pediatr. 2021. PMID: 34670265 Review.
CD40 ligand/CD40 deficiency.
Castigli E, Fuleihan R, Ramesh N, Tsitsikov E, Tsytsykova A, Geha RS. Castigli E, et al. Among authors: fuleihan r. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):37-9. doi: 10.1159/000236923. Int Arch Allergy Immunol. 1995. PMID: 7542090 Free article. Review.
Primary immunodeficiency: a never ending story.
Etzioni A, Fuleihan R. Etzioni A, et al. Among authors: fuleihan r. Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):503-4. doi: 10.1097/ACI.0b013e32834cd2b2. Curr Opin Allergy Clin Immunol. 2011. PMID: 21971336 No abstract available.
Allergy, immunology, and related disorders.
Fuleihan RL. Fuleihan RL. Curr Opin Pediatr. 1998 Dec;10(6):581-3. doi: 10.1097/00008480-199810060-00007. Curr Opin Pediatr. 1998. PMID: 9848016 Review. No abstract available.
Chapter 27: Approach to primary immunodeficiency.
Uzzaman A, Fuleihan RL. Uzzaman A, et al. Among authors: fuleihan rl. Allergy Asthma Proc. 2012 May-Jun;33 Suppl 1:91-95. doi: 10.2500/aap.2012.33.3560. Allergy Asthma Proc. 2012. PMID: 22794700 Review.
A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.
Hernandez-Trujillo V, Zhou C, Scalchunes C, Ochs HD, Sullivan KE, Cunningham-Rundles C, Fuleihan RL, Bonilla FA, Petrovic A, Rawlings DJ, de la Morena MT. Hernandez-Trujillo V, et al. Among authors: fuleihan rl. J Clin Immunol. 2023 Aug;43(6):1468-1477. doi: 10.1007/s10875-023-01502-x. Epub 2023 May 23. J Clin Immunol. 2023. PMID: 37219739 Free PMC article.
Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis.
Horesh ME, Martin-Fernandez M, Gruber C, Buta S, Le Voyer T, Puzenat E, Lesmana H, Wu Y, Richardson A, Stein D, Hodeib S, Youssef M, Kurowski JA, Feuille E, Pedroza LA, Fuleihan RL, Haseley A, Hovnanian A, Quartier P, Rosain J, Davis G, Mullan D, Stewart O, Patel R, Lee AE, Rubinstein R, Ewald L, Maheshwari N, Rahming V, Chinn IK, Lupski JR, Orange JS, Sancho-Shimizu V, Casanova JL, Abul-Husn NS, Itan Y, Milner JD, Bustamante J, Bogunovic D. Horesh ME, et al. Among authors: fuleihan rl. J Exp Med. 2024 Jun 3;221(6):e20232387. doi: 10.1084/jem.20232387. Epub 2024 Apr 2. J Exp Med. 2024. PMID: 38563820
111 results